title: Can corporatization contribute to quality assurance and cost control in the German hospital sector? A pilot project for stem cell transplantation.
authors.forename: R
authors.initials: R
authors.lastname: Walshe
authors.forename: N
authors.initials: N
authors.lastname: Schmitz
authors.forename: V
authors.initials: V
authors.lastname: Diehl
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D003363:Cost Control; D005858:Germany; D006287:Health Planning Guidelines; D018380:Hematopoietic Stem Cell Transplantation / Q000191:economics*; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D016522:Oncology Service, Hospital / Q000191:economics / Q000458:organization & administration* / Q000592:standards; D010865:Pilot Projects; D011332:Privatization; D011785:Quality Assurance, Health Care; D012042:Registries; D013673:Technology Assessment, Biomedical / Q000639:trends
chemical_list: D000970:Antineoplastic Agents